|
thyroidectomy |
18 |
|
thyroid cancer |
15 |
|
thyroiditis |
12 |
|
covid-19 |
11 |
|
sars-cov-2 |
11 |
|
thyroid function tests |
11 |
|
thyroid gland |
11 |
|
quality of life |
10 |
|
young adult |
10 |
|
neoplasm staging |
9 |
|
recurrent laryngeal nerve |
9 |
|
thyroid nodule |
8 |
|
adolescent |
7 |
|
adult |
7 |
|
aged |
7 |
|
aged, 80 and over |
7 |
|
carcinoma, papillary - genetics - metabolism - pathology |
7 |
|
child |
7 |
|
female |
7 |
|
graves’ disease |
7 |
|
humans |
7 |
|
male |
7 |
|
middle aged |
7 |
|
papillary thyroid carcinoma |
7 |
|
reverse transcriptase polymerase chain reaction |
7 |
|
thyroid neoplasms |
7 |
|
thyroid neoplasms - genetics - metabolism - pathology |
7 |
|
ultrasonography |
7 |
|
alanine |
6 |
|
animals |
6 |
|
case-control studies |
6 |
|
cell proliferation |
6 |
|
cell transformation, neoplastic - genetics - metabolism |
6 |
|
electrophoretic mobility shift assay |
6 |
|
follow up |
6 |
|
gene expression regulation, neoplastic |
6 |
|
germ-line mutation |
6 |
|
goiter, nodular - genetics - metabolism - pathology |
6 |
|
health care |
6 |
|
hypoparathyroidism |
6 |
|
immunoblotting |
6 |
|
luciferases - diagnostic use |
6 |
|
nuclear proteins - genetics - metabolism |
6 |
|
primary hyperparathyroidism |
6 |
|
radioactive iodine |
6 |
|
rats |
6 |
|
signal transduction - genetics |
6 |
|
survivorship |
6 |
|
thyroid gland - cytology - metabolism |
6 |
|
thyroidectomy - methods |
6 |
|
transcription factors - genetics - metabolism |
6 |
|
transcription, genetic |
6 |
|
up-regulation |
6 |
|
valine |
6 |
|
ablation techniques |
5 |
|
breast cancer |
5 |
|
calcitonin - blood |
5 |
|
central neck dissection |
5 |
|
eq-5d-5 l |
5 |
|
genetic screening |
5 |
|
genetic testing |
5 |
|
high-intensity focused ultrasound ablation |
5 |
|
multinodular goiter |
5 |
|
multiple endocrine neoplasia |
5 |
|
multiple endocrine neoplasia type 2a |
5 |
|
multiple endocrine neoplasia type 2a - genetics - surgery |
5 |
|
paraganglioma |
5 |
|
pheochromocytoma |
5 |
|
proliferation |
5 |
|
proteomics |
5 |
|
proto-oncogene proteins c-ret |
5 |
|
psychometric properties |
5 |
|
radiofrequency ablation |
5 |
|
reliability |
5 |
|
responsiveness |
5 |
|
succinate dehydrogenase |
5 |
|
surgery |
5 |
|
thypro-39 |
5 |
|
thyroglobulin |
5 |
|
thyroid neoplasms - genetics - prevention and control - surgery |
5 |
|
ttf1 |
5 |
|
validity |
5 |
|
antithyroid drugs |
4 |
|
cell differentiation |
4 |
|
chinese |
4 |
|
hypermethylation |
4 |
|
interventional ultrasonography |
4 |
|
iodine radioisotopes - therapeutic use |
4 |
|
killin |
4 |
|
neoplasms, second primary - epidemiology |
4 |
|
nodular goiter |
4 |
|
nodule shrinkage |
4 |
|
parathyroidectomy |
4 |
|
population based cohort |
4 |
|
pten |
4 |
|
radiotherapy |
4 |
|
retrospective studies |
4 |
|
robotic thyroidectomy |
4 |
|
thermal ablation |
4 |
|
thyroid carcinoma |
4 |
|
thyroid neoplasms - pathology - radiotherapy |
4 |
|
total thyroidectomy |
4 |
|
acoustic analysis |
3 |
|
adenoma - radionuclide imaging - surgery - ultrasonography |
3 |
|
anaplastic thyroid cancer |
3 |
|
calcium blood level |
3 |
|
carcinoid |
3 |
|
central lymph nodes |
3 |
|
cosmin |
3 |
|
dysphonia |
3 |
|
endoscopic thyroidectomy |
3 |
|
everolimus |
3 |
|
focussed ultrasound |
3 |
|
healthcare utilisation |
3 |
|
hyperparathyroidism |
3 |
|
hyperparathyroidism, primary - etiology |
3 |
|
hyperplasia |
3 |
|
hypothyroidism |
3 |
|
intra-operative neuro-monitoring |
3 |
|
measurement property |
3 |
|
minimally invasive parathyroidectomy |
3 |
|
mortality |
3 |
|
neoplasms, second primary - complications - epidemiology - mortality - radiotherapy |
3 |
|
nerve monitoring |
3 |
|
neuroendocrine |
3 |
|
non-robotic thyroidectomy |
3 |
|
opioid |
3 |
|
pain |
3 |
|
pancreatic |
3 |
|
parathyroid adenoma |
3 |
|
parathyroid hormone blood level |
3 |
|
parathyroid neoplasms - radionuclide imaging - surgery - ultrasonography |
3 |
|
persistent opioid use |
3 |
|
postoperative outcomes |
3 |
|
postoperative period |
3 |
|
psychometrics |
3 |
|
quality of recovery |
3 |
|
re-operation |
3 |
|
recurrent laryngeal nerve palsy |
3 |
|
sunitinib |
3 |
|
systematic review |
3 |
|
tc99m-sestamibi scintigraphy |
3 |
|
technetium tc 99m sestamibi |
3 |
|
thypro |
3 |
|
thyroid |
3 |
|
thyroid disease |
3 |
|
thyroid neoplasms - complications - epidemiology - mortality - pathology - radiotherapy - secondary - surgery |
3 |
|
thyroid nodules |
3 |
|
trans-laryngeal ultrasonography |
3 |
|
treatment outcome |
3 |
|
vocal cord palsy |
3 |
|
vocal cord paresis |
3 |
|
voice |
3 |
|
young age |
3 |
|
abdominal surgery |
2 |
|
ablation therapy |
2 |
|
adenocarcinoma, follicular - complications - mortality |
2 |
|
adenocarcinoma, follicular - genetics - metabolism - pathology |
2 |
|
adenocarcinoma, papillary - blood |
2 |
|
adenoma - surgery |
2 |
|
analgesia |
2 |
|
anti-thyroglobulin autoantibody |
2 |
|
anticoagulants |
2 |
|
benign thyroid nodule |
2 |
|
braf mutation |
2 |
|
cancer death |
2 |
|
cancer incidence |
2 |
|
cancer staging |
2 |
|
carcinoma, papillary - complications - mortality |
2 |
|
carcinoma, papillary - surgery |
2 |
|
cardiac surgery |
2 |
|
central compartment neck dissection |
2 |
|
cervical plexus block (cpb) |
2 |
|
cost effectiveness |
2 |
|
cost-effectiveness analysis |
2 |
|
cyclin-dependent kinase inhibitor p16 - genetics - metabolism |
2 |
|
differentiated thyroid carcinoma |
2 |
|
disease-specific death |
2 |
|
dna methylation |
2 |
|
dna, neoplasm - genetics - metabolism |
2 |
|
economic burden |
2 |
|
endocrine ophthalmopathy |
2 |
|
endocrine surgical procedures |
2 |
|
endoscopy |
2 |
|
expression |
2 |
|
fine-needle aspiration |
2 |
|
fluorocholine |
2 |
|
fluorodeoxyglucose |
2 |
|
fnac |
2 |
|
focused ultrasound |
2 |
|
follicular thyroid carcinoma |
2 |
|
general surgery |
2 |
|
goiter, nodular |
2 |
|
graves' disease |
2 |
|
hemorrhage |
2 |
|
hypercalcemia |
2 |
|
hyperplasia - surgery |
2 |
|
hyperthermia, induced |
2 |
|
immunoenzyme techniques |
2 |
|
induced hyperthermia |
2 |
|
iodine |
2 |
|
laryngeal ultrasound |
2 |
|
liver metastasis |
2 |
|
major clinical study |
2 |
|
marker |
2 |
|
medicine & public health |
2 |
|
methylation |
2 |
|
monitoring, intraoperative - methods |
2 |
|
neck extension |
2 |
|
neoplasm metastasis |
2 |
|
neoplasm recurrence, local - blood |
2 |
|
neoplasms, second primary - etiology - mortality |
2 |
|
neuroendocrine tumor |
2 |
|
nodal negative papillary thyroid cancer |
2 |
|
nodular goitre |
2 |
|
nomogram |
2 |
|
oncology |
2 |
|
p16 |
2 |
|
pain management |
2 |
|
pancreas |
2 |
|
pancreatectomy |
2 |
|
parathyroid carcinoma |
2 |
|
parathyroid neoplasm |
2 |
|
platelet aggregation inhibitors |
2 |
|
positron emission tomography |
2 |
|
postoperative hypocalcemia |
2 |
|
postoperative pain |
2 |
|
predicting recurrence |
2 |
|
preoperative |
2 |
|
promoter regions, genetic |
2 |
|
prophylactic central neck dissection (pcnd) |
2 |
|
qalys |
2 |
|
quality-of-life |
2 |
|
radiofrequency ablation (rfa) |
2 |
|
radiopharmaceuticals - diagnostic use |
2 |
|
randomized controlled trial |
2 |
|
randomized trial |
2 |
|
relapse |
2 |
|
risk stratification |
2 |
|
rna, messenger - genetics - metabolism |
2 |
|
robotics |
2 |
|
robotics - methods |
2 |
|
sedation |
2 |
|
staging |
2 |
|
surgical oncology |
2 |
|
surveillance |
2 |
|
thoracic surgery |
2 |
|
thyroid dysfunction |
2 |
|
thyroid gland - cancer - classification. |
2 |
|
thyroid gland - cancer - prognosis. |
2 |
|
thyroid incidentaloma |
2 |
|
thyroid neoplasm |
2 |
|
thyroid neoplasms - blood |
2 |
|
thyroid neoplasms - complications - mortality |
2 |
|
thyroid neoplasms - mortality - pathology - surgery |
2 |
|
thyroid neoplasms - pathology - therapy |
2 |
|
thyroid neoplasms - surgery |
2 |
|
thyrotoxicosis |
2 |
|
trachea |
2 |
|
treatment efficacy |
2 |
|
tumor markers, biological - blood |
2 |
|
ultrasonic imaging |
2 |
|
ultrasonography, interventional |
2 |
|
ultrasound imaging |
2 |
|
vagus nerve stimulation |
2 |
|
vascular endothelial growth factor a - blood |
2 |
|
vascular endothelial growth factor c - blood |
2 |
|
vascular surgery |
2 |
|
abdominal wall - blood supply |
1 |
|
academic medical centers |
1 |
|
adenocarcinoma - pathology - secondary - therapy |
1 |
|
adenocarcinoma, follicular - diagnosis - surgery |
1 |
|
adenocarcinoma, follicular - pathology - secondary - therapy |
1 |
|
adenocarcinoma, follicular - pathology - therapy |
1 |
|
adenocarcinoma, papillary - mortality - pathology - radiotherapy - surgery |
1 |
|
adenocarcinoma, papillary - mortality - pathology - surgery |
1 |
|
adenocarcinoma, papillary - pathology - therapy |
1 |
|
airway obstruction |
1 |
|
airway obstruction - etiology - surgery |
1 |
|
antineoplastic agents - therapeutic use |
1 |
|
antineoplastic combined chemotherapy protocols - toxicity |
1 |
|
ata risk stratification |
1 |
|
benign substernal goitre |
1 |
|
biochemical phenomena |
1 |
|
breast neoplasms - drug therapy - mortality - pathology |
1 |
|
cancer surgery |
1 |
|
capsular invasion |
1 |
|
carcinoma - drug therapy - radiotherapy - surgery |
1 |
|
carcinoma - pathology - therapy |
1 |
|
carcinoma, papillary |
1 |
|
carcinoma, papillary - diagnosis - surgery |
1 |
|
carcinoma, papillary - mortality - pathology |
1 |
|
carcinoma, papillary - mortality - pathology - surgery |
1 |
|
carcinoma, papillary - pathology - secondary - therapy |
1 |
|
central compartment |
1 |
|
cervical lymph node metastasis |
1 |
|
cholecalciferol - deficiency |
1 |
|
combined modality therapy |
1 |
|
cushing's syndrome. |
1 |
|
disease recurrence |
1 |
|
disease-free survival |
1 |
|
distant metastasis |
1 |
|
doxorubicin - administration and dosage - analogs and derivatives - therapeutic use - toxicity |
1 |
|
elderly |
1 |
|
electrocautery |
1 |
|
emergency intubation |
1 |
|
en bloc resection |
1 |
|
endoscopic surgery |
1 |
|
enucleation |
1 |
|
epigastric |
1 |
|
etiology |
1 |
|
fine needle aspiration cytology |
1 |
|
fluorodeoxyglucose f18 - diagnostic use |
1 |
|
follicular neoplasm |
1 |
|
gastroenterology |
1 |
|
goiter, nodular - complications - surgery |
1 |
|
goiter, nodular - epidemiology - mortality - pathology - surgery |
1 |
|
gynecology |
1 |
|
hemithyroidectomy |
1 |
|
hepatology |
1 |
|
hernia, ventral - etiology - surgery |
1 |
|
high intensity focused ultrasound |
1 |
|
hrpt2 gene mutations |
1 |
|
hyperparathyroidism - surgery |
1 |
|
hyperparathyroidism. |
1 |
|
hypocalcemia |
1 |
|
hypocalcemia - etiology |
1 |
|
hypoparathyroidism - complications - radionuclide imaging - surgery |
1 |
|
hypothyroidism - blood - epidemiology - etiology |
1 |
|
indeterminate cytology |
1 |
|
insulinoma |
1 |
|
intubation, intratracheal |
1 |
|
liposomal doxorubicin |
1 |
|
locoregional recurrence |
1 |
|
lymph node excision |
1 |
|
lymph node metastasis |
1 |
|
lymph node yield |
1 |
|
lymphatic metastasis |
1 |
|
lymphovascular invasion |
1 |
|
metastases |
1 |
|
morbidity |
1 |
|
neck dissection |
1 |
|
neoplasm invasiveness |
1 |
|
neoplasm invasiveness - pathology |
1 |
|
neoplasm metastasis - drug therapy - pathology |
1 |
|
neoplasm recurrence, local |
1 |
|
neoplasm staging - instrumentation |
1 |
|
neoplasm staging - methods |
1 |
|
neuromonitoring |
1 |
|
nodal metastasis |
1 |
|
pancreatic fistula |
1 |
|
papillary thyroid carcinoma (ptc) |
1 |
|
papillary thyroid microcarcinoma (ptmc) |
1 |
|
parathyroid gland identification (pg identification) |
1 |
|
parathyroid hormone |
1 |
|
parathyroid hormone - blood |
1 |
|
parathyroid neoplasms - complications - diagnosis - surgery |
1 |
|
parathyroid neoplasms - surgery |
1 |
|
parathyroidectomy - adverse effects - methods |
1 |
|
parathyroidectomy - methods |
1 |
|
patient safety |
1 |
|
polyethylene glycols - administration and dosage - therapeutic use - toxicity |
1 |
|
positron-emission tomography |
1 |
|
postoperative complications - blood - epidemiology |
1 |
|
postoperative complications - diagnosis - etiology - prevention and control |
1 |
|
postoperative complications - epidemiology |
1 |
|
postoperative hypoparathyroidism |
1 |
|
postoperative outcome |
1 |
|
proctology |
1 |
|
prognosis |
1 |
|
prognostic factors |
1 |
|
recurrence |
1 |
|
recurrent laryngeal nerve - physiology |
1 |
|
recurrent laryngeal nerve injuries |
1 |
|
recurrent laryngeal nerve injury |
1 |
|
referral and consultation |
1 |
|
reoperation |
1 |
|
reproducibility of results |
1 |
|
response to therapy |
1 |
|
risk factors |
1 |
|
robotic adrenalectomy |
1 |
|
robotic pancreatectomy |
1 |
|
robotic parathyroidectomy |
1 |
|
statistics, nonparametric |
1 |
|
surgical outcome |
1 |
|
surgical procedures, minimally invasive |
1 |
|
survival |
1 |
|
survival analysis |
1 |
|
survival rate |
1 |
|
technetium tc 99m sestamibi - diagnostic use |
1 |
|
thyroid neoplasms - diagnosis |
1 |
|
thyroid neoplasms - drug therapy - radiotherapy - surgery |
1 |
|
thyroid neoplasms - mortality - pathology |
1 |
|
thyroid neoplasms - mortality - pathology - radiotherapy - surgery |
1 |
|
thyroid neoplasms - pathology - surgery |
1 |
|
thyroidectomy - adverse effects - methods |
1 |
|
thyroidectomy - mortality |
1 |
|
tnm |
1 |
|
tnm staging |
1 |
|
tracheostomy |
1 |
|
ventral hernia |
1 |
|
vinorelbine |
1 |
|
vitamin d deficiency - complications |
1 |
